Cargando…

The actions of BAFF in B-lymphocyte maturation and its effects on the development of autoimmune disease

Detalles Bibliográficos
Autor principal:	Melchers, F
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833807/ http://dx.doi.org/10.1186/ar817

Ejemplares similares

B cell activating factor (BAFF) and platelet activating factor (PAF) could both be markers of non-IgE-mediated reactions
por: Piuri, G, et al.
Publicado: (2013)

Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations
por: Mackay, Fabienne, et al.
Publicado: (1999)

Crucial Role for BAFF-BAFF-R Signaling in the Survival and Maintenance of Mature B Cells
por: Rauch, Melanie, et al.
Publicado: (2009)

Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression
por: Pahl, Madeleine V., et al.
Publicado: (2010)

S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES
por: Dillon, Stacey, et al.
Publicado: (2023)

Complement, its role in innate immunity and autoimmunity
por: Daha, M
Publicado: (2003)

April and Baff Connect Autoimmunity and Cancer
por: Ware, Carl F.
Publicado: (2000)

The effects of BAFF on T lymphocytes in chronic obstructive pulmonary disease
por: Gao, Shupei, et al.
Publicado: (2020)

Role of CD5/CD5L interactions in the homeostasis of regulatory lymphocyte subpopulations and the control of autoimmune disorders
por: Fenutría, Rafael, et al.
Publicado: (2011)

BAFF polymorphisms and serum levels of BAFF in Tunisian systemic lupus erythematosus patients
por: Laamiri, Nacira, et al.
Publicado: (2012)

How does BAFF activate B cells in patients with autoimmune diseases?
por: Mariette, Xavier
Publicado: (2012)

Baff Mediates Survival of Peripheral Immature B Lymphocytes
por: Batten, Marcel, et al.
Publicado: (2000)

Development of Bevirimat (PA-457): first-in-class HIV maturation inhibitor
por: Allaway, Graham P
Publicado: (2006)

Mechanisms driving heme insertion into apo-sGC during its maturation in cells
por: Stuehr, Dennis, et al.
Publicado: (2013)

The current status of targeting BAFF/BLyS for autoimmune diseases
por: Ramanujam, Meera, et al.
Publicado: (2004)

BAFF- and APRIL-targeted therapy in systemic autoimmune diseases
por: Nakayamada, Shingo, et al.
Publicado: (2016)

Regulation of inflammatory immune responses leading to the development of bone destructive autoimmune disease rheumatoid arthritis by IL-27
por: Yoshimoto, Takayuki, et al.
Publicado: (2012)

Adipocytokines and autoimmunity
por: Frommer, Klaus W, et al.
Publicado: (2011)

BAFF and BAFF-Receptor in B Cell Selection and Survival
por: Smulski, Cristian R., et al.
Publicado: (2018)

Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes
por: Wilkie, S, et al.
Publicado: (2008)

Autoimmune diabetes: mechanisms
por: Cooke, A
Publicado: (2005)

Role of BH3-only protein Bim in autoimmune and degenerative diseases
por: Bouillet, P, et al.
Publicado: (2003)

Evading p53 action during tumor development and therapy
por: Lowe, SW
Publicado: (2005)

Follow up study of B-lymphocyte depletion in the treatment of patients with systemic lupus erythematosus
por: Leandro, MJ, et al.
Publicado: (2005)

Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate
por: Ursu, S, et al.
Publicado: (2011)

Antimalarial activity of ulein and proof of its action on the Plasmodium falciparum digestive vacuole
por: de Oliveira, Alaíde Braga, et al.
Publicado: (2010)

Proteomic surveillance of autoimmunity in osteoarthritis
por: Kato, T, et al.
Publicado: (2003)

Immunity and autoimmunity in breast cancer
por: Curigliano, G
Publicado: (2011)

Death receptor-induced apoptosis signalling - essential guardian against autoimmune disease
por: Strasser, Andreas, et al.
Publicado: (2012)

Signal transduction in T lymphocytes
por: Cantrell, D
Publicado: (2005)

Cytosolic phospholipase A2α gene silencing in monocytes alters development of Th1 responses and reduces autoimmune arthritis
por: Courties, G, et al.
Publicado: (2010)

B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease
por: Giordano, Daniela, et al.
Publicado: (2023)

The prevalence of obesity in mature Icelandic horses in Denmark
por: Jensen, Rasmus Bovbjerg, et al.
Publicado: (2015)

Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves’ disease
por: Wang, Xin, et al.
Publicado: (2021)

Genetic control of T-cell autoimmunity and arthritis
por: Holmdahl, R
Publicado: (2004)

Dermatological manifestations in autoimmune thyroid disorders
por: Nagaraj, N, et al.
Publicado: (2012)

Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
por: Gros, Alena, et al.
Publicado: (2015)

The effect and the mechanism of allo-bone marrow mesenchymal stem cells in experimental autoimmune thyroiditis
por: Zheng, Rongxiu, et al.
Publicado: (2015)

The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity
por: Vincent, Fabien B., et al.
Publicado: (2013)

Complement and autoimmunity: new insights into old questions
por: Holers, VM, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_acd8g8b3351tsgo44d6t46bdga